MNCs pivot to innovative medicines
September 29, 2022 | 12:18
Multinational corporations are making moves to separate from generics units to focus more on innovative drugs to gain higher profits.
Sandoz leading in generics and biosimilar medicines in Vietnam
August 29, 2022 | 11:46
Sandoz (a division of Novartis) – one of the world's leading companies in high-quality generics and biosimilar – is mapping its business in Vietnam.
Answers around corner for market authorisation renewal
April 28, 2022 | 09:00
A steady supply of medicines coming into Vietnam could be ensured imminently after the government announced the deadline for amendments to existing drug registration rules in order to facilitate business operations.
Vietnam-made medicines swallowing a bitter pill
September 11, 2012 | 15:19
Vietnam-made medicines are losing out to due consumers’ and doctors’ obsession with foreign products.
Mobile Version